INBX vs. AXTI
INBX (Inhibrx, Inc.) and AXTI (AXT, Inc.) are both stocks. INBX operates in Biotechnology (Healthcare), while AXTI operates in Semiconductor Equipment & Materials (Technology). Over the past year, INBX returned 279.86% vs 3047.40% for AXTI. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
INBX vs. AXTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INBX achieves a 3.86% return, which is significantly lower than AXTI's 269.60% return.
INBX
- 1D
- -3.16%
- 1M
- -15.92%
- 6M
- 7.58%
- YTD
- 3.86%
- 1Y
- 279.86%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 133.63%
AXTI
- 1D
- 28.74%
- 1M
- 6.73%
- 6M
- 225.94%
- YTD
- 269.60%
- 1Y
- 3,047.40%
- 3Y*
- 169.71%
- 5Y*
- 42.74%
- 10Y*
- 32.40%
- ALL TIME*
- 6.40%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AXTI AXT, Inc. | $521.22M | $514.43M | $822.68M |
INBX Inhibrx, Inc. | $16.81M | $26.81M | $39.34M |
INBX vs. AXTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
INBX Inhibrx, Inc. | 3.86% | 412.99% | 18.46% |
AXTI AXT, Inc. | 269.60% | 653.46% | -41.51% |
Correlation
The correlation between INBX and AXTI is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (All Time) Calculated using the full available price history since May 29, 2024 | 0.19 |
Fundamentals
INBX:
$1.20B
AXTI:
$3.07B
INBX:
-$8.39
AXTI:
$0.08
INBX:
979.34
AXTI:
24.26
INBX:
$1.30M
AXTI:
$125.51M
INBX:
-$508.00K
AXTI:
$40.39M
INBX:
-$117.63M
AXTI:
$17.91M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INBX vs. AXTI — Risk / Return Rank
INBX
AXTI
INBX vs. AXTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Inhibrx, Inc. (INBX) and AXT, Inc. (AXTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INBX | AXTI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -16.86 | ||
| Sortino ratioReturn per unit of downside risk | -1.25 | ||
| Omega ratioGain probability vs. loss probability | 1.51 | 1.64 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 6.26 | 38.57 | -32.31 |
| Martin ratioReturn relative to average drawdown | 13.63 | 117.62 | -103.99 |
Loading charts...
Drawdowns
INBX vs. AXTI - Drawdown Comparison
The maximum INBX drawdown since its inception was -44.13%, smaller than the maximum AXTI drawdown of -98.57%. Use the drawdown chart below to compare losses from any high point for INBX and AXTI.
Loading charts...
Drawdown Indicators
| INBX | AXTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.13% | -98.57% | +54.44% |
Max Drawdown (1Y)Largest decline over 1 year | -44.13% | -73.75% | +29.62% |
Max Drawdown (3Y)Largest decline over 3 years | — | -78.52% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -88.79% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -92.45% | — |
Current DrawdownCurrent decline from peak | -42.15% | -57.09% | +14.94% |
Average DrawdownAverage peak-to-trough decline | -18.21% | -82.15% | +63.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.24% | 24.14% | -3.90% |
Volatility
INBX vs. AXTI - Volatility Comparison
The current volatility for Inhibrx, Inc. (INBX) is 18.59%, while AXT, Inc. (AXTI) has a volatility of 57.24%. This indicates that INBX experiences smaller price fluctuations and is considered to be less risky than AXTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INBX | AXTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.59% | 57.24% | -38.65% |
Volatility (6M)Calculated over the trailing 6-month period | 60.80% | 122.91% | -62.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 128.60% | 149.65% | -21.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 98.09% | 100.30% | -2.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 98.09% | 85.23% | +12.86% |
Dividends
INBX vs. AXTI - Dividend Comparison
Neither INBX nor AXTI has paid dividends to shareholders.
Financials
INBX vs. AXTI - Financials Comparison
This section allows you to compare key financial metrics between Inhibrx, Inc. and AXT, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
INBX and AXTI have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AXTI has higher volatility (57.24%) compared to INBX (18.59%). In terms of maximum drawdown, INBX dropped -44.13% vs AXTI's -98.57%.
AXTI currently has the higher Sharpe Ratio (19.01 vs 2.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INBX and AXTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer